393
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Prior irradiation results in elevated programmed cell death protein 1 (PD-1) in T cells

, , , &
Pages 488-494 | Received 12 Jun 2017, Accepted 30 Oct 2017, Published online: 29 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Deguan Li, Yong Guan, Yinping Dong, Jing Wu, Yuanyang Zhang, Renxiang Chen, Yun-Tien Lin, Albert J. Fornace, Heng-Hong Li & Zhiyong Yuan. (2021) Radiochemotherapy upregulates expression of checkpoint receptors on circulating T cells. International Journal of Radiation Biology 97:11, pages 1563-1568.
Read now
Mohsen Sisakht, Maryam Darabian, Amir Mahmoodzadeh, Ali Bazi, Sayed Mohammad Shafiee, Pooneh Mokarram & Zahra Khoshdel. (2020) The role of radiation induced oxidative stress as a regulator of radio-adaptive responses. International Journal of Radiation Biology 96:5, pages 561-576.
Read now

Articles from other publishers (17)

Li-Fang Shen, Zi-Ming Fu & Shui-Hong Zhou. (2023) The role of radiotherapy in tumor immunity and the potential of PET/CT in detecting the expression of PD-1/PD-L1. Japanese Journal of Radiology.
Crossref
Li Wang, Siyu Wang, Jiayu Zhang, Jianmin Peng, Bin Cheng, Huan Li & Qinchao Hu. (2023) Radiotherapy upregulated immune checkpoints contribute to the development of second primary OSCC . Oral Diseases.
Crossref
Jiao-jiao Ni, Zi-zhen Zhang, Ming-jie Ge, Jing-yu Chen & Wei Zhuo. (2022) Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights. Acta Pharmacologica Sinica 44:2, pages 288-307.
Crossref
J. M. Herter, M. Kiljan, S. Kunze, M. Reinscheid, O. Ibruli, J. Cai, L. Niu, I. Heßelmann, M. Trommer, G. S. Herter-Sprie, C. Köhler & S. Marnitz. (2022) Influence of chemoradiation on the immune microenvironment of cervical cancer patients. Strahlentherapie und Onkologie 199:2, pages 121-130.
Crossref
Mahdi Abdoli Shadbad, Zahra Asadzadeh, Negar Hosseinkhani, Afshin Derakhshani, Nazila Alizadeh, Oronzo Brunetti, Nicola Silvestris & Behzad Baradaran. (2021) A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology. Frontiers in Immunology 12.
Crossref
Gregor Manukian, Charles Kivolowitz, Tiziana DeAngelis, Anuradha A. Shastri, Jason E. Savage, Kevin Camphausen, Ulrich Rodeck, Jelani C. Zarif & Nicole L. Simone. (2021) Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells. International Journal of Radiation Oncology*Biology*Physics 110:5, pages 1341-1349.
Crossref
Adrian Witzleben, Adrian Fehn, Ayla Grages, Jasmin Ezić, Sandra S. Jeske, Lisa K. Puntigam, Cornelia Brunner, Johann M. Kraus, Hans A. Kestler, Johannes Doescher, Matthias Brand, Marie‐Nicole Theodoraki, Christian H. Ottensmeier, Thomas K. Hoffmann, Patrick J. Schuler & Simon Laban. (2020) Prospective longitudinal study of immune checkpoint molecule ( ICM ) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma ( HNSCC ) . International Journal of Cancer 148:8, pages 2023-2035.
Crossref
Hiroshi Fukushima, Soichiro Yoshida, Toshiki Kijima, Yuki Nakamura, Shohei Fukuda, Sho Uehara, Yosuke Yasuda, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka & Yasuhisa Fujii. (2021) Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti–PD-1 Treatment Efficacy in Urothelial Carcinoma. International Journal of Molecular Sciences 22:2, pages 535.
Crossref
Lijun Li, Renxiang Chen, Yun-Tien Lin, Arslon Humayun, Albert J. FornaceJr.Jr. & Heng-Hong Li. (2021) 3,3'-Diindolylmethane Enhances Tumor Regression After Radiation Through Protecting Normal Cells to Modulate Antitumor Immunity. Advances in Radiation Oncology 6:1, pages 100601.
Crossref
Lydia S. Lamb, Hao-Wen Sim & Ann I. McCormack. (2020) Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy. Frontiers in Endocrinology 11.
Crossref
Chaoxu Zhang, Yibo Fan, Xiaofang Che, Min Zhang, Zhi Li, Ce Li, Shuo Wang, Ti Wen, Kezuo Hou, Xinye Shao, Yunpeng Liu & Xiujuan Qu. (2020) Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28. Frontiers in Oncology 10.
Crossref
Paola Ciciola, Priscilla Cascetta, Cataldo Bianco, Luigi Formisano & Roberto Bianco. (2020) Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents. Journal of Clinical Medicine 9:3, pages 675.
Crossref
Jie Huang & Jian Jian Li. (2020) Cell repopulation, rewiring metabolism, and immune regulation in cancer radiotherapy. Radiation Medicine and Protection 1:1, pages 24-30.
Crossref
Jie Huang & Jian Jian Li. 2020. Tumor Microenvironment. Tumor Microenvironment 175 202 .
Lawrence Kleinberg, Lindsey Sloan, Stuart Grossman & Michael Lim. (2019) Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy. Neurosurgery 85:4, pages 441-453.
Crossref
Gregor Manukian, Voichita Bar-Ad, Bo Lu, Athanassios Argiris & Jennifer M. Johnson. (2019) Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology 9.
Crossref
Ming Yi, Dechao Jiao, Hanxiao Xu, Qian Liu, Weiheng Zhao, Xinwei Han & Kongming Wu. (2018) Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors. Molecular Cancer 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.